Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
SCHILLER AG
AMPRONIX

Radiosurgery Suite Receives US Clearance for Noninvasive Surgical Procedures

By Medimaging International staff writers
Posted on 20 Feb 2013
Image: The Edge radiosurgery suite (Photo courtesy of Varian Medical Systems).
Image: The Edge radiosurgery suite (Photo courtesy of Varian Medical Systems).
A new dedicated radiosurgery system has been developed for performing radiosurgery using real-time tumor tracking and motion management technologies.

Varian Medical Systems (Palo Alto, CA, USA) has received US Food and Drug Administration (FDA) 510(k) clearance for the company’s Edge radiosurgery suite. “The Edge suite represents a new paradigm in radiosurgery, offering clinicians a system that combines Varian’s world-class technologies in an end-to-end solution for planning and delivering radiosurgery treatments,” said Chris Toth, vice president of marketing for Varian’s oncology systems business. “It integrates Varian’s state-of-the-art radiosurgery technology with tools for real-time imaging, tracking, and patient positioning. It enables fast, accurate delivery of stereotactic radiosurgery for treating lesions, tumors, and conditions anywhere in the body where radiotherapy is indicated, including tumors of the lung, prostate, spine, and brain.”

Recent FDA 510(k) clearances cover the following technologies that are integrated into the Edge radiosurgery suite. These new technologies are also being made available as upgrades to other compatible Varian systems: The PerfectPitch couch, which is an integrated 6° of freedom (6DoF) treatment couch that provides the precision, accuracy, and flexibility required to position patients optimally, adjust their position to correct for any misalignments, and support them comfortably during treatment. The couch has been designed for the accuracy and functionality required to provide radiosurgery treatments in the brain and in the rest of the body.

The advanced motion and image-guided radiotherapy (IGRT) package is a sophisticated motion management package that offers clinicians many options for using real-time imaging during radiotherapy treatments. It also enables expanded use of fluoroscopy and four-dimensional (4D) cone-beam computed tomography (CT)—imaging techniques that show motion over time—to better compensate for tumor motion during treatment.

The intracranial radiosurgery package is an integrated set of technologies for planning and delivering stereotactic radiosurgery treatments for tumors or functional abnormalities in the brain. The intracranial radiosurgery package supports the accurate delivery of radiation using multiple beam-shaping options, including Varian's high-definition multileaf collimator and radiosurgery conical collimators, and is compatible with both frame-based and frameless patient immobilization approaches.

Lastly, the Calypso system, which has several enhancements, have been incorporated into the Calypso system for real time tracking. The system utilizes transponders, or position signaling devices, that are implanted in or around a tumor, or placed on the surface of the body and monitored to track motion during treatment. New enhancements increase the rate of transponder signal processing in order to track faster types of motion, such as respiratory motion, in real time. The system is also compatible with the couch rotations that are frequently employed to optimize targeting during treatments in the lung. The technology also includes updated usability features designed to streamline treatments and optimize the user experience.

One optional Edge suite subcomponent is still pending FDA 510(k) clearance: Calypso anchored Beacon transponders for implantation in the lung to guide lung radiosurgery procedures.

Related Links:

Varian Medical Systems




RTI ELECTRONICS AB
SuperSonic Imagine
RADCAL

Channels

MRI

view channel

Use of Breast MRI Offers Optimized Care

Magnetic resonance imaging (MRI) is being used increasingly for breast cancer screening, diagnostic assessment, treatment planning, and monitoring; however, a recent study revealed that over time, the indication for breast MRI has changed. Much of the increase was found among women with breast cancer risk factors, but there... Read more

Ultrasound

view channel
Image: Analogic Sonic Window handheld ultrasound for peripheral IV placement (Photo courtesy of Analogic).

First-of-a-Kind Ultrasound System Designed for Image-Guided Peripheral Intravenous Access and Fits in Pocket

A new, ultra-compact ultrasound device provides direct visualization of structures beneath the skin in real time to effectively guide clinicians placing peripheral intravenous (IV) lines.... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.